2011
DOI: 10.1002/ajmg.a.33968
|View full text |Cite
|
Sign up to set email alerts
|

SMAD4 mutation segregating in a family with juvenile polyposis, aortopathy, and mitral valve dysfunction

Abstract: Juvenile polyposis syndrome (JPS) is caused by heterozygous mutations in either SMAD4 or BMPR1A. Individuals with JPS due to mutations in SMAD4 are at greater risk to manifest signs of hereditary hemorrhagic telangiectasia (HHT). HHT is caused by either mutations in SMAD4 or other genes that modulate transforming growth factor-beta (TGFβ) signaling. Additional genes in the TGFβ network include FBN1, TGFBR1, and TGFBR2, mutations of which cause either Marfan syndrome (MFS) or Loeys-Dietz syndrome (LDS), respect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
60
0
3

Year Published

2013
2013
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(65 citation statements)
references
References 22 publications
2
60
0
3
Order By: Relevance
“…The symptoms of HHT include epistaxis, telangiectases, and arteriovenous malformations, which are most often found in the lungs, brain, liver and gastrointestinal tract. In addition, SMAD4 mutations have been identified in families with juvenile polyposis, aortophathy, and mitral valve dysfunction (Andrabi et al, 2011 humans with IRF6 mutation, whereas Irf6 +/R84C mice do not show digit developmental defects. These results suggest that a compromised SMAD-dependent, TGFβ-mediated IRF6 signaling cascade might be responsible for developmental defects associated with PPS.…”
Section: Discussionmentioning
confidence: 99%
“…The symptoms of HHT include epistaxis, telangiectases, and arteriovenous malformations, which are most often found in the lungs, brain, liver and gastrointestinal tract. In addition, SMAD4 mutations have been identified in families with juvenile polyposis, aortophathy, and mitral valve dysfunction (Andrabi et al, 2011 humans with IRF6 mutation, whereas Irf6 +/R84C mice do not show digit developmental defects. These results suggest that a compromised SMAD-dependent, TGFβ-mediated IRF6 signaling cascade might be responsible for developmental defects associated with PPS.…”
Section: Discussionmentioning
confidence: 99%
“…To explain how mutation of TGF-β signal-related molecules, especially in inflammatory cells, leads to damage or remodeling of the vascular system, we can use the mechanism of hereditary hemorrhagic telangiectasia (HHT). HHT is caused by mutations of several TGF-β signal-related molecules, including ALK1, endoglin, and Smad4 (49,50), and mutation of Smad4, an obligate partner of Smad3, could induce the dilation of aorta (49). At the early stage of HHT development, lymphocytes, includ-and TGF-β (10 ng/ml) (R&D Systems).…”
Section: Methodsmentioning
confidence: 99%
“…Similarly, SMAD4 was recently implicated in human aortic disease. A pedigree was described with the combination of juvenile polyposis, aortopathy, and mitral valve disease (Andrabi et al 2011). Aortic aneurysm with pathologic evidence of cystic medial necrosis was noted in aortic tissue from a mutation carrier.…”
Section: Canonical (Smad) and Noncanonical (Mapk) Tgf-b Signalingmentioning
confidence: 99%
“…þ/2 mice ) as well as aortopathy in humans caused by loss of function mutations in SMAD3 and SMAD4 (van de Laar et al 2010;Andrabi et al 2011). It could also help explain the skewed mutational repertoire in TGF-b receptor mutations (LDS) favoring intact receptor complexes unable to transduce canonical signaling .…”
Section: Canonical (Smad) and Noncanonical (Mapk) Tgf-b Signalingmentioning
confidence: 99%